Rare diseases
Investigational molecules
Locations
Phase 3 Extension Trial Evaluating Long‑Term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity
BelgiumStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
AustriaA Phase 3 Randomized, Double-blind,Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Participants with Obstructive Sleep Apnea not on Positive Airway Pressure Therapy and Living with Overweight or Obesity (MARITIME-OSA-2)
CzechiaLong‑term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity and Type 2 Diabetes
BulgariaStudy of Maridebart Cafraglutide for Adults with Obstructive Sleep Apnea and Overweight or Obesity Who Use Positive Airway Pressure Therapy
CzechiaStudy on the Effectiveness and Safety of Maridebart Cafraglutide for Adults with Obesity or Overweight Without Type 2 Diabetes
BelgiumStudy on the Effects of Maridebart Cafraglutide for Adults with Type 2 Diabetes
AustriaA study testing maridebart cafraglutide for weight loss in adults with overweight or obesity, with or without type 2 diabetes
CzechiaStudy on Maridebart Cafraglutide for Adults with Type 2 Diabetes and Obesity or Overweight
BulgariaTell us about your condition – we search every trial in Europe and connect you with the right site.
